SYDNI ALEXIS GOLFIN

Allopathic & Osteopathic Physicians|Internal Medicine MOUNT CLEMENS, MI NPI 1821789256

General Payments — all program years on this page

$1,243.60

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 28
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,101.00 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,101.0021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $142.607
2024 $1,101.0021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078052512 Janssen Pharmaceuticals, Inc $15.21 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078894143 Actelion Pharmaceuticals US, Inc. $31.05 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080705952 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $87.76 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080705958 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $12.26 09/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093880997 Alexion Pharmaceuticals, Inc. $18.48 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096827272 Novo Nordisk Inc $23.43 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103813544 ABBVIE INC. $15.92 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130752883 Nevro Corp. $26.86 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130752889 Nevro Corp. $134.29 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130752891 Nevro Corp. $8.06 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131085133 PFIZER INC. $20.37 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131619031 PFIZER INC. $21.88 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132038542 PFIZER INC. $21.94 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134596899 CSL Behring $124.74 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139827134 SANOFI-AVENTIS U.S. LLC $124.74 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139827180 GENZYME CORPORATION $126.00 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139827182 GENZYME CORPORATION $126.00 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139827238 GENZYME CORPORATION $107.10 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140136847 Integra LifeSciences Corporation $17.52 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144615049 Xeris Pharmaceuticals, Inc. $16.79 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154899617 Kiniksa Pharmaceuticals International, plc $20.60 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.